Target intelligence / Profile preview

Complement C1q tumor necrosis factor-related protein 5 (C1QTNF5)

Target
C1QTNF5
Molecular classification
Other (C1q/TNF superfamily protein), Secreted protein, Membrane-associated protein
01

Overview

Complement C1q tumor necrosis factor-related protein 5 (C1QTNF5) is a member of the C1q/tumor necrosis factor (TNF) superfamily that is strongly expressed in retinal pigment epithelium cells. The protein contains a signal peptide, a collagen domain, and a globular C1q-like domain, and it forms both trimeric and higher-order multimeric structures. C1QTNF5 is essential for maintaining retinal structure and function; mutations (notably S163R and others) cause autosomal dominant late-onset retinal degeneration (L-ORD), a disorder characterized by progressive loss of night vision and retinal degeneration appearing in middle age. C1QTNF5 is secreted and may be attached to membranes, playing a role in cell adhesion and interactions within the retinal extracellular matrix. Some functions of C1QTNF5 remain incompletely understood; in mouse, it also regulates adipose tissue browning and autophagy. At present, C1QTNF5 is not established as a direct therapeutic target or receptor, and there are no known drugs that target it directly.

Other names
C1q and TNF related 5CTRP5complement-c1q tumor necrosis factor-related protein 5C1q TNF-alpha-related protein 5C1q and tumor necrosis factor related protein 5myonectinUNQ303/PRO344DKFZp586B0621LORDmembrane frizzled-related proteinMFRP (though MFRP refers primarily to a separate but co-transcribed gene/protein)
02

Biological functions

Maintenance of retinal structure and functionCell adhesionBasement membrane componentRegulation of retinal pigment epithelium functionRegulation of adipose tissue browning (mouse)
03

Disease associations

Retinal degeneration (specifically late-onset retinal degeneration, L-ORD)Macular dystrophy
04

Biomarkers

C1QTNF5 mutations (specifically S163R, P188T, G216C) are used as genetic markers for susceptibility to late-onset retinal degeneration (L-ORD)

Beyond the preview

Go deeper on Complement C1q tumor necrosis factor-related protein 5 (C1QTNF5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complement C1q tumor necrosis factor-related protein 5 (C1QTNF5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call